Radioresponse and prognosis of malignant glioma.
Radioresponse and prognosis of 91 malignant gliomas were studied to examine the efficacy of radiotherapy. There was no case of complete response. No statistically significant difference was observed among the prognoses of patients with various radiation methods. General survival rate was significantly higher than relapse-free survival rate both in astrocytoma grade III and in glioblastoma. This means that the retreatment after relapse is exceedingly important in any malignant glioma. In comparison with reported resection alone data, the efficiency of radiotherapy was evident in astrocytoma grade III and a part of glioblastoma; cases with minimal or no contrast enhanced area (CEA) in CT scans prior to irradiation. Poor radioresponders of glioblastoma with CEA should be reoperated.
Yamada
S
S
Department of Radiology, Tohoku University School of Medicine, Sendai, Japan.
Takai
Y
Y
Nemoto
K
K
Ogawa
Y
Y
Kakuto
Y
Y
Hoshi
A
A
Sakamoto
K
K
Kayama
T
T
Yoshimoto
T
T
D000293:Adolescent; D000328:Adult; D000368:Aged; D001254:Astrocytoma / Q000000981:diagnostic imaging / Q000532:radiotherapy; D001921:Brain / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D005260:Female; D005910:Glioma / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D011379:Prognosis; D012008:Recurrence; D015996:Survival Rate; D014057:Tomography, X-Ray Computed